Current strategies, including surgery, radiation, and chemotherapies, can have serious side effects and are generally not curative. The Brain Tumor Center (BTC) at Memorial Sloan Kettering Cancer ...

In the paper published in Nature Communications, the novel drug CT-179 was shown to target a specific subset of tumor cells responsible for recurrence and therapy resistance in pediatric brain cancer.